Clinical trial
Molecular Markers of Prognosis in Colorectal Cancer Patients
NCT00220142 · Royal Marsden NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00220142 |
|---|---|
| Title | Molecular Markers of Prognosis in Colorectal Cancer Patients |
| Official title | Molecular Markers of Prognosis in Colorectal Cancer Patients |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Colorectal Cancer |
| Enrollment | 103 |
| Start date | Nov 1, 2003 |
| First posted | Sep 22, 2005 |
| Last update posted | May 31, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: